The number of involved extracranial organs

A new predictor of survival in breast cancer patients with brain metastasis

Lavinia Gerdan, Barbara Segedin, Viorica Nagy, Mai T. Khoa, Ngo T. Trang, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective This study was performed to investigate the potential impact of the number of involved extracranial organs on survival in patients with brain metastasis from breast cancer. Methods The data of 196 patients treated with whole-brain radiotherapy (WBRT) alone for brain metastases from breast cancer were retrospectively analyzed. Six potential prognostic factors were evaluated for associations with survival. These factors included WBRT regimen, age, Karnofsky performance score (KPS), number of brain metastases, interval from breast cancer diagnosis to WBRT, and the number of involved extracranial organs. Results The 6-month survival rates of patients with involvement of 0, 1, 2, 3 and ≥4 extracranial organs were 59%, 49%, 26%, 26% and 13%, respectively, and the 12-month survival rates were 45%, 36%, 17%, 17% and 13%, respectively (p < 0.001). On multivariate analysis, the number of involved extracranial organs (risk ratio 1.17; 95%-confidence interval 1.02-1.35; p = 0.028) maintained significance, as did KPS (p < 0.001), but not age (p = 0.27). Conclusion The number of involved extracranial organs is an independent prognostic factor of survival in patients with brain metastasis from breast cancer.

Original languageEnglish (US)
Pages (from-to)2108-2110
Number of pages3
JournalClinical Neurology and Neurosurgery
Volume115
Issue number10
DOIs
StatePublished - Oct 2013

Fingerprint

Breast Neoplasms
Neoplasm Metastasis
Survival
Brain
Radiotherapy
Survival Rate
Tissue Survival
Multivariate Analysis
Odds Ratio
Confidence Intervals

Keywords

  • Brain metastasis
  • Breast cancer
  • Involvement of extracranial organs
  • Prognostic factors
  • Survival

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

The number of involved extracranial organs : A new predictor of survival in breast cancer patients with brain metastasis. / Gerdan, Lavinia; Segedin, Barbara; Nagy, Viorica; Khoa, Mai T.; Trang, Ngo T.; Schild, Steven E.; Rades, Dirk.

In: Clinical Neurology and Neurosurgery, Vol. 115, No. 10, 10.2013, p. 2108-2110.

Research output: Contribution to journalArticle

Gerdan, Lavinia ; Segedin, Barbara ; Nagy, Viorica ; Khoa, Mai T. ; Trang, Ngo T. ; Schild, Steven E. ; Rades, Dirk. / The number of involved extracranial organs : A new predictor of survival in breast cancer patients with brain metastasis. In: Clinical Neurology and Neurosurgery. 2013 ; Vol. 115, No. 10. pp. 2108-2110.
@article{529f1f29197142db95da4e5a937ababe,
title = "The number of involved extracranial organs: A new predictor of survival in breast cancer patients with brain metastasis",
abstract = "Objective This study was performed to investigate the potential impact of the number of involved extracranial organs on survival in patients with brain metastasis from breast cancer. Methods The data of 196 patients treated with whole-brain radiotherapy (WBRT) alone for brain metastases from breast cancer were retrospectively analyzed. Six potential prognostic factors were evaluated for associations with survival. These factors included WBRT regimen, age, Karnofsky performance score (KPS), number of brain metastases, interval from breast cancer diagnosis to WBRT, and the number of involved extracranial organs. Results The 6-month survival rates of patients with involvement of 0, 1, 2, 3 and ≥4 extracranial organs were 59{\%}, 49{\%}, 26{\%}, 26{\%} and 13{\%}, respectively, and the 12-month survival rates were 45{\%}, 36{\%}, 17{\%}, 17{\%} and 13{\%}, respectively (p < 0.001). On multivariate analysis, the number of involved extracranial organs (risk ratio 1.17; 95{\%}-confidence interval 1.02-1.35; p = 0.028) maintained significance, as did KPS (p < 0.001), but not age (p = 0.27). Conclusion The number of involved extracranial organs is an independent prognostic factor of survival in patients with brain metastasis from breast cancer.",
keywords = "Brain metastasis, Breast cancer, Involvement of extracranial organs, Prognostic factors, Survival",
author = "Lavinia Gerdan and Barbara Segedin and Viorica Nagy and Khoa, {Mai T.} and Trang, {Ngo T.} and Schild, {Steven E.} and Dirk Rades",
year = "2013",
month = "10",
doi = "10.1016/j.clineuro.2013.07.030",
language = "English (US)",
volume = "115",
pages = "2108--2110",
journal = "Clinical Neurology and Neurosurgery",
issn = "0303-8467",
publisher = "Elsevier",
number = "10",

}

TY - JOUR

T1 - The number of involved extracranial organs

T2 - A new predictor of survival in breast cancer patients with brain metastasis

AU - Gerdan, Lavinia

AU - Segedin, Barbara

AU - Nagy, Viorica

AU - Khoa, Mai T.

AU - Trang, Ngo T.

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2013/10

Y1 - 2013/10

N2 - Objective This study was performed to investigate the potential impact of the number of involved extracranial organs on survival in patients with brain metastasis from breast cancer. Methods The data of 196 patients treated with whole-brain radiotherapy (WBRT) alone for brain metastases from breast cancer were retrospectively analyzed. Six potential prognostic factors were evaluated for associations with survival. These factors included WBRT regimen, age, Karnofsky performance score (KPS), number of brain metastases, interval from breast cancer diagnosis to WBRT, and the number of involved extracranial organs. Results The 6-month survival rates of patients with involvement of 0, 1, 2, 3 and ≥4 extracranial organs were 59%, 49%, 26%, 26% and 13%, respectively, and the 12-month survival rates were 45%, 36%, 17%, 17% and 13%, respectively (p < 0.001). On multivariate analysis, the number of involved extracranial organs (risk ratio 1.17; 95%-confidence interval 1.02-1.35; p = 0.028) maintained significance, as did KPS (p < 0.001), but not age (p = 0.27). Conclusion The number of involved extracranial organs is an independent prognostic factor of survival in patients with brain metastasis from breast cancer.

AB - Objective This study was performed to investigate the potential impact of the number of involved extracranial organs on survival in patients with brain metastasis from breast cancer. Methods The data of 196 patients treated with whole-brain radiotherapy (WBRT) alone for brain metastases from breast cancer were retrospectively analyzed. Six potential prognostic factors were evaluated for associations with survival. These factors included WBRT regimen, age, Karnofsky performance score (KPS), number of brain metastases, interval from breast cancer diagnosis to WBRT, and the number of involved extracranial organs. Results The 6-month survival rates of patients with involvement of 0, 1, 2, 3 and ≥4 extracranial organs were 59%, 49%, 26%, 26% and 13%, respectively, and the 12-month survival rates were 45%, 36%, 17%, 17% and 13%, respectively (p < 0.001). On multivariate analysis, the number of involved extracranial organs (risk ratio 1.17; 95%-confidence interval 1.02-1.35; p = 0.028) maintained significance, as did KPS (p < 0.001), but not age (p = 0.27). Conclusion The number of involved extracranial organs is an independent prognostic factor of survival in patients with brain metastasis from breast cancer.

KW - Brain metastasis

KW - Breast cancer

KW - Involvement of extracranial organs

KW - Prognostic factors

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84884531468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884531468&partnerID=8YFLogxK

U2 - 10.1016/j.clineuro.2013.07.030

DO - 10.1016/j.clineuro.2013.07.030

M3 - Article

VL - 115

SP - 2108

EP - 2110

JO - Clinical Neurology and Neurosurgery

JF - Clinical Neurology and Neurosurgery

SN - 0303-8467

IS - 10

ER -